Association between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves’ Disease Study

<table>Distribution of serum TRAb values in patients with newly diagnosed hyperthyroidism caused by Graves’ disease and enrolled in the RISG study. According to inclusion criteria, none had TRAb &lt; 1.0 IU/L. Up to 40 IU/L, intervals are 2.5 IU/L wide. At 40 IU/L and above, intervals are 20 IU/L wide.</table>

Journal of Thyroid Research

fig3

Figure 3

Figure 3: Association between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves’ Disease Study 

Figure 3 | Association between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves’ Disease Study 